<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43349">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01659125</url>
  </required_header>
  <id_info>
    <org_study_id>DIEF003581HI</org_study_id>
    <nct_id>NCT01659125</nct_id>
  </id_info>
  <brief_title>Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)</brief_title>
  <official_title>Effectiveness and Neuropsychological Predictors of Guided Self-Help for OCD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hartford Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hartford Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to learn about who is most likely to benefit from guided
      self-help (GSH) for obsessive-compulsive disorder (OCD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 Participants with OCD will be recruited.  They will be given access to OC Fighter, an
      internet OCD treatment program. During the 17 week program, participants will meet with a
      therapist 9 times.  Assessments will occur at pretreatment, post-treatment, 3-month follow
      up and 6-month follow up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)</measure>
    <time_frame>Change in Y-BOCS will be assessed over the course of the 17 week treatment trial, then again three months and six months after the treatment.</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>OCFighter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>OCFighter</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>&quot;OCFighter&quot;</intervention_name>
    <description>OCFighterâ„¢ s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD.  The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).</description>
    <arm_group_label>OCFighter</arm_group_label>
    <other_name>OCFighter</other_name>
    <other_name>Guided Self-help</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Principal or co-principal diagnosis of OCD

          -  Clinical global impression score greater than or equal to 4

          -  Y-BOCS score great than or equal to 16

          -  Fluency in English

          -  Capacity to understand the nature of the study and willingness to sign informed
             consent form

        Exclusion Criteria:

          -  Active manic episode, psychosis, pervasive developmental disorder, mental retardation

          -  Concurrent OCD psychotherapy

          -  Current threat of harm to self or others

          -  Previous adequate trial of therapist-administered or self-administered exposure and
             response prevention for OCD
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gretchen Diefenbach, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hartford Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gretchen Diefenbach, Ph.D.</last_name>
    <phone>860-545-7396</phone>
    <email>GDiefen@Harthosp.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretchen Diefenbach, Ph.D.</last_name>
      <phone>860-545-7396</phone>
      <email>GDiefen@harthosp.org</email>
    </contact>
    <investigator>
      <last_name>Gretchen Diefenbach, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 18, 2013</lastchanged_date>
  <firstreceived_date>August 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
